Red flags / Dilution

SLSSELLAS Life Sciences Group Inc.SevereForm 424B5filed Nov 19, 4:07 PM ET

SELLAS Life Sciences to sell 11.5 million shares at $13.00 in $150 million offering

SELLAS Life Sciences Group is offering 11,538,462 shares of common stock at a public offering price of $13.00 per share, for gross proceeds of about $150.0 million before underwriting discounts and expenses, with net proceeds to the company of about $141.0 million. The price is a discount to the $17.95 closing price on November 18, 2026, and the underwriters hold a 30-day option to buy up to 1,730,769 additional shares. Dilution from an offering of this size can weigh on existing holders' ownership and per-share value.

“We are offering 11,538,462 shares of our common stock.”

What the stock did

From the last close before the filing was public. Market cap now: $2.8B.

1 day
-8.1%
SPY -3.6%
5 days
Not yet
 
20 days
Not yet
 

Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on SLS

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 17, 4:14 PM ETSLS
SELLAS Life Sciences Group Inc.
Dilution
ElevatedForm 424B5
SELLAS Life Sciences files for $150 million common stock offering$2.8B--